Purpose of the development: For prevention and treatment: - rickets and rickets-like diseases in children; - D-hypovitaminosis in pregnant women; mineral metabolism disorders; - osteopathies of various genesis (osteomalacia, osteoporosis, orthopedic deformities, fractures of limbs, etc.) in the treatment of diabetes; - cardiovascular diseases, rheumatoid arthritis, and the like.

Recommended application field: The medicine. Populations of all ages with a risk of vitamin D deficiency.

Advantages over analogues: An innovative proposal for the drug "Videin D3-E" is the use of vitamins D3 and E in a protein-bound state. Due to the formation of stable complexes of vitamins and protein, the drug significantly exceeds the world analogues in bioavailability, efficacy and shelf life (up to 4 years).

The development stage readiness: tested in laboratory condition

Description of the development:
()
Vitamin D3-E protein complex in vitamin D3 is in a double protective complex against oxidation: from the inside, vitamin D3 is stabilized by a cholesterol molecule, and on the outside it is covered with highly purified milk protein - casein. In addition, the drug contains vitamin E, which in the body additionally protects vitamin D3 from oxidation in the gastrointestinal tract. The production of therapeutic and prophylactic vitamin preparation D3-E protein complex can be mass-produced on standard equipment of pharmaceutical enterprises.

Information about newness of the development:
there are Ukrainian patents -- 1 items

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Combinated reduction to industrial level
Joint production, sale, exploitation

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua